News Ticker

Biotech Networks Trending News

  • San Francisco
  • Boston/Cambridge
  • San Diego
  • Pennsylvania NY NJ
  • DC Maryland Virginia
  • Washington/Oregon
  • Los Angeles
BioConsortia Unveils Broadened Nematicide Seed Treatment Pipeline
Mammoth Biosciences Announces Appointment of Phil Tinmouth, Siang Chin to Key Leadership Roles
Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus
Philip Tagari switches Amgen's discovery lab for insitro's machine learning tools; CEO Joaquin Duato to chair J&J's board
Guardant Health to Showcase New Data at San Antonio Breast Cancer Symposium 2022 Demonstrating Utility of Its Blood Tests for Advanced-stage Breast Cancer Patients
Verana Health to Enable Cloud-based Access to its Curated, De-identified Real-World Data Through AWS Data Exchange
ADDF STATEMENT ON LECANEMAB DATA PRESENTED AT CTAD
Allogene takes the stage in New York to go deep on its off-the-shelf cell therapies — declaring a first for solid tumors
Candesant® Biomedical Announces Publication of Pilot Study Data on a Novel, Non-invasive Medical Device for the Reduction of Axillary Hyperhidrosis
Twist Bioscience finds itself the target of synthetic biology short-seller Scorpion Capital
Podimetrics Closes Out Strong Growth Year with Two Executive Hires, New Board Member
Fractyl Health Announced Positive Proof-of-Concept Data of Pancreatic GLP-1 Gene Therapy in a Type 2 Diabetes Animal Model at the 20th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
X4 Pharmaceuticals pulls together some positive data results after a rocky year
Boston Scientific shells out $615M for gastro device firm
Alzheimer's Association Statement on Lecanemab Phase 3 Full Results
Eisai’s expanded Alzheimer’s data leave open questions about safety and clinical benefit
EISAI PRESENTS FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER'S DISEASE AT CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE
Bisnow: As Boston Biotech Overflows, Its Suburbs Go Platinum To Soak Up The Spillover
Merck to hire another 100 at newly expanded Cambridge research lab
STAT+: Pharmalittle: Pfizer employees balk at returning overpayments; Biogen stops work on another ALS drug
Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-827104 in Pediatric Patients with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep
European Commission lays groundwork to unwind Illumina's $7B+ Grail merger
MEI Pharma Announces Adjournment of Annual Meeting of Stockholders
AbbVie puts up $40M to license a treatment from HotSpot Therapeutics
Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas
San Diego's Avalon BioVentures raises $135M to invest in biotech, health care startups
Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
As FDA door shuts on its PI3K, MEI Pharma throws in the towel, lays off staff
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH
A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial
SABCS roundup: Novartis shows two-year PFS in breast cancer subgroups; AstraZeneca reveals more Enhertu data
Florida judge dismisses Zantac cancer claims against GSK, other pharmas
13 Philadelphia-area hospitals are tops for maternity care, according to U.S. News
Gossamer’s Faheem Hasnain defends a round of positive PAH data as a clear win. But can these PhII results stand up to scrutiny?
'Where would the world be without nurses?' J&J refreshes campaign honoring health workers
Rebuffed suitor Stonebridge Healthcare tries once more to buy Tower Health
Frontage Central Labs is Awarded the Prestigious CAP Accreditation from the College of American Pathologists
Boehringer Ingelheim buys CD38 drug; Merck bets on machine learning in antibody design
Nabriva stock up after firm's antibiotic shows promise as a potential cystic fibrosis treatment
IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline
Germantown biotech gets $50M in funding to further cell therapy manufacturing
Horizon Therapeutics spells out vision for Rockville R&D hub
NaxSwab™ OTC novel naloxone nasal swab demonstrates faster absorption and higher early exposures against other naloxone products in clinical study
FDA Approves First Fecal Microbiota Product
Merck sues Johns Hopkins for licensing Keytruda patents in secret and in conflict with research collaboration
Catalent to cut about 200 jobs in Maryland and Texas
AstraZeneca Showcases Strength of Hematology Portfolio and Pipeline Across Multiple Hard-to-Treat Conditions at ASH 2022
FDA Roundup: November 29, 2022
Life Sciences Firm Closing 2 Maryland Facilities, Laying Off Workers
AstraZeneca Aims to Redefine Breast Cancer Care With New Data Across the Treatment Spectrum At SABCS 2022
OHA brings in reinforcements for children's hospitals struggling with RSV
Hot Topics in Neonatology® 2022 Conference Will Include Symposium on Benefits of Vat Pasteurization for Human Donor Milk
Health Care Leadership Award: Sean Gibbons, Institute for Systems Biology
McMinnville in-home care startup HelloCare elevates care giver support
CommonSpirit Health Provides Cyberattack Update and Notification of Data Breach Involving Virginia Mason Franciscan Health in Washington state
Ambulance company AMR plans layoffs for 100-plus employees in Pierce County
CTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit
Aurion Biotech Expands Its Leadership Team
Seattle-area Health Startup One Item Expands CDC-Backed Heart Study
5 Oregon health care lawsuits that could rock the industry in 2023
SABCS roundup: Novartis shows two-year PFS in breast cancer subgroups; AstraZeneca reveals more Enhertu data
SARS-CoV-2 Virus Kinetics Influenced by Viral Strain and Vaccination Status
Third Annual Survey Reveals Telehealth Popularity Growing Among Older Adults
OutcomeMD Closes Investment Round with $3.7M from Future Ventures
TigerConnect Appoints Healthcare Executive Adrienne Kirby to Board of Directors
Horizon Therapeutics in takeover talks with Amgen, J&J, Sanofi as potential buyers
Virgin Orbit CEO to Present at Morgan Stanley’s 5th Annual Space Summit
Horizon Therapeutics plc Confirms Preliminary Discussions Regarding Potential Offer
IEHP supports new moms with mental health events
German biotech CatalYm raises $50M to flip weight loss target for cancer

Biotech Networks Jobs: Remote Jobs

Follow/Subscribe

© 2022 Biotech Networks, LLC